The Journal of Immunology, Vol 155, Issue 9 4179-4188, Copyright © 1995 by American Association of Immunologists

ARTICLES

A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers

YL Colson, SM Wren, MJ Schuchert, KD Patrene, PC Johnson, SS Boggs and ST Ildstad
Department of Surgery, University of Pittsburgh, PA 15261, USA.

Reconstitution of lethally irradiated mice with a mixture of syngeneic and allogeneic (A+B-->A) bone marrow results in multilineage mixed allogeneic chimerism, donor-specific transplantation tolerance, superior immunocompetence and resistance to graft-vs-host disease. However, the morbidity and mortality associated with lethal irradiation would be a major limitation to the clinical application of chimerism to induce tolerance for solid organ grafts or treat other nonmalignant hematologic diseases. We report here that durable multilineage mixed allogeneic chimerism and donor-specific transplantation tolerance for skin and primarily vascularized allografts can be achieved across multiple histocompatibility barriers using a nonmyeloablative radiation- based approach. The percentage of B10 mouse recipients that engrafted directly correlated with the degree of disparity between donor and recipient and the dose of total body irradiation administered. Although the occurrence of engraftment following conditioning with doses of total body irradiation of > or = 600 cGy was similar for animals receiving bone marrow disparate at MHC or MHC, minor and hematopoietic (Hh-1) loci (67% vs 78%), the level of donor chimerism was significantly less when multiple histocompatibility barriers were present (94.6 +/- 3.8% vs 37.5 +/- 12.5%). Treatment of the recipient with cyclophosphamide 2 days following allogeneic bone marrow transplantation reduced the dose of radiation sufficient for reliable engraftment to only 500 cGy of total body irradiation, regardless of MHC and Hh-1 disparity. Donor chimerism was stable and present in all lineages, with production of lymphoid (T and B cell), NK, and myeloid (erythrocyte, platelet, granulocyte, and macrophage) cells. Mixed chimeras exhibited donor-specific tolerance in vitro, as assessed by mixed lymphocyte culture (MLR) and cytotoxicity (CML) assays, and in vivo to skin and primarily vascularized cardiac allografts. The observation that engraftment and tolerance can be achieved across multiple histocompatibility barriers using nonmyeloablative recipient conditioning may allow allogeneic bone marrow transplantation to be applied to nonmalignant disease states in which lethal conditioning cannot be justified, including the induction of donor-specific tolerance for solid organ transplantation and the treatment of hemoglobinopathies and enzyme deficiency states.

This article has been cited by other articles:

				H. Xu, P. M. Chilton, M. K. Tanner, Y. Huang, C. L. Schanie, M. Dy-Liacco, J. Yan, and S. T. Ildstad Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients Blood, November 15, 2006; 108(10): 3611 - 3619. [Abstract] [Full Text] [PDF]

				B. Dawn, Y. Guo, A. Rezazadeh, Y. Huang, A. B. Stein, G. Hunt, S. Tiwari, J. Varma, Y. Gu, S. D. Prabhu, et al. Postinfarct Cytokine Therapy Regenerates Cardiac Tissue and Improves Left Ventricular Function Circ. Res., April 28, 2006; 98(8): 1098 - 1105. [Abstract] [Full Text] [PDF]

				S. T. Ildstad, P. M. Chilton, H. Xu, M. A. Domenick, and M. B. Ray Preconditioning of NOD mice with anti-CD8 mAb and costimulatory blockade enhances chimerism and tolerance and prevents diabetes, while depletion of {alpha}{beta}-TCR+ and CD4+ cells negates the effect Blood, March 15, 2005; 105(6): 2577 - 2584. [Abstract] [Full Text] [PDF]

				H. Xu, B. G. Exner, P. M. Chilton, C. Schanie, and S. T. Ildstad CD45 Congenic Bone Marrow Transplantation: Evidence for T Cell-Mediated Immunity Stem Cells, November 1, 2004; 22(6): 1039 - 1048. [Abstract] [Full Text] [PDF]

				H. Xu, P. M. Chilton, Y. Huang, C. L. Schanie, and S. T. Ildstad Production of Donor T Cells Is Critical for Induction of Donor-Specific Tolerance and Maintenance of Chimerism J. Immunol., February 1, 2004; 172(3): 1463 - 1471. [Abstract] [Full Text] [PDF]

				N. Askenasy, E. S. Yoleuk, H. Shirwan, Z. Wang, and D. L. Farkas Cardiac Allograft Acceptance after Localized Bone Marrow Transplantation by Isolated Limb Perfusion in Nonmyeloablated Recipients Stem Cells, March 1, 2003; 21(2): 200 - 207. [Abstract] [Full Text] [PDF]

				S. Hayashi, W. H. Peranteau, A. F. Shaaban, and A. W. Flake Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion Blood, July 18, 2002; 100(3): 804 - 812. [Abstract] [Full Text] [PDF]

				H. Xu, B. G. Exner, D. E. Cramer, M. K. Tanner, Y. M. Mueller, and S. T. Ildstad CD8+, {alpha}{beta}-TCR+, and {gamma}{delta}-TCR+ Cells in the Recipient Hematopoietic Environment Mediate Resistance to Engraftment of Allogeneic Donor Bone Marrow J. Immunol., February 15, 2002; 168(4): 1636 - 1643. [Abstract] [Full Text] [PDF]

				N. Askenasy and D. L. Farkas Antigen Barriers or Available Space Do Not Restrict in Situ Adhesion of Hemopoietic Cells to Bone Marrow Stroma Stem Cells, January 1, 2002; 20(1): 80 - 85. [Abstract] [Full Text] [PDF]

				L. Luznik, S. Jalla, L. W. Engstrom, R. Iannone, and E. J. Fuchs Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide Blood, December 1, 2001; 98(12): 3456 - 3464. [Abstract] [Full Text] [PDF]

				F. Lan, D. Zeng, P. Huie, J. P. Higgins, and S. Strober Allogeneic bone marrow cells that facilitate complete chimerism and eliminate tumor cells express both CD8 and T-cell antigen receptor-{alpha}{beta} Blood, June 1, 2001; 97(11): 3458 - 3465. [Abstract] [Full Text] [PDF]

				P. J. Quesenberry, S. Zhong, H. Wang, and M. Stewart Allogeneic chimerism with low-dose irradiation, antigen presensitization, and costimulator blockade in H-2 mismatched mice Blood, January 15, 2001; 97(2): 557 - 564. [Abstract] [Full Text] [PDF]

				A. Umemura, A. P. Monaco, and T. Maki Donor MHC Class II Antigen Is Essential for Induction of Transplantation Tolerance by Bone Marrow Cells J. Immunol., May 1, 2000; 164(9): 4452 - 4457. [Abstract] [Full Text] [PDF]

				R. Storb, C. Yu, T. Barnett, J. L. Wagner, H. J. Deeg, R. A. Nash, H.-P. Kiem, P. McSweeney, K. Seidel, G. Georges, et al. Stable Mixed Hematopoietic Chimerism in Dog Leukocyte Antigen-Identical Littermate Dogs Given Lymph Node Irradiation Before and Pharmacologic Immunosuppression After Marrow Transplantation Blood, August 1, 1999; 94(3): 1131 - 1136. [Abstract] [Full Text] [PDF]

				R. Storb, C. Yu, J. L. Wagner, H. J. Deeg, R. A. Nash, H.-P. Kiem, W. Leisenring, and H. Shulman Stable Mixed Hematopoietic Chimerism in DLA-Identical Littermate Dogs Given Sublethal Total Body Irradiation Before and Pharmacological Immunosuppression After Marrow Transplantation Blood, April 15, 1997; 89(8): 3048 - 3054. [Abstract] [Full Text] [PDF]

				A. de Vries-van der Zwan, A. C. Besseling, L. P. de Waal, and C. J.P. Boog Specific Tolerance Induction and Transplantation: A Single-Day Protocol Blood, April 1, 1997; 89(7): 2596 - 2601. [Abstract] [Full Text] [PDF]